X

Vous n'êtes pas connecté

Maroc Maroc - THEMARKETHERALD.CA - A La Une - 19/Aug 17:04

Satellos Biosciences to advance DMD treatment to clinical trials

Satellos Biosciences (TSX:MSCL) reveals it has received approval to begin a Phase 1 clinical trial in Australia for SAT-3247.

Articles similaires

Sorry! Image not available at this time

Worldwide Clinical Trials - APAC: Senior / Clinical Trial Manager - CNS - Australia

pharmiweb.com - 09/Sep 00:00

Competitive: Worldwide Clinical Trials - APAC: Who we are Worldwide Clinical Trials (Worldwide), a leading global contract research organization...

Sorry! Image not available at this time

Clinical Pharmacist – Operations Manager at IQVIA

jobwebkenya.com - 19:05

IQVIA, formerly Quintiles and IMS Health, Inc.,is an American multinational company serving the combined industries of health information technology...

Sorry! Image not available at this time

Nxera Pharma to get US$ 35 mn from Neurocrine for successful completion of phase 2 trial with NBI─1117568 in adults with schizophrenia

pharmabiz.com - 03/Sep 00:00

Nxera Pharma Co., Ltd.(formerly known as Sosei Group or Sosei Heptares), announces that it will receive a US$ 35 million payment from Neurocrine...

Sorry! Image not available at this time

8th MASH Drug Development Summit

pharmiweb.com - 02/Sep 04:49

Madrigal's blockbuster drug gaining FDA approval this March has opened the doors to a wave of therapeutics from Eli Lilly, Boehringer Ingelheim,...

Sorry! Image not available at this time

MindBio advances world-first psychedelic microdosing clinical trials

themarketherald.ca - 29/Aug 14:44

MindBio Therapeutics (CSE:MBIO) announces the successful completion of its Phase 1 and 2a clinical trials on depression treatment.

Sorry! Image not available at this time

First Patients Treated in Phase 2 Clinical Trial of STAT3 Inhibitor in Combination with Radiation for the Treatment of Glioblastoma

drugs.com - 09/Sep 20:09

HOUSTON, Sept. 9, 2024. Moleculin Biotech, Inc., ("Moleculin" or the "Company), a Phase 3 clinical-stage pharmaceutical company with a broad portfolio...

NIH awards $15.5 million to expand clinical trials inclusion for nursing home residents

news.medical.net - 29/Aug 19:36

A team led by research scientists from the Indiana University School of Medicine and Regenstrief Institute has received funding expected to total...

Sorry! Image not available at this time

Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX─121 to treat patients with Hunter syndrome

pharmabiz.com - 04/Sep 00:00

Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...

Sorry! Image not available at this time

Regenxbio reports positive results from phase I/II/III CAMPSIITE trial of RGX─121 to treat patients with Hunter syndrome

pharmabiz.com - 04/Sep 00:00

Regenxbio Inc., a leading clinical─stage biotechnology company, announced positive results from the phase I/II/III CAMPSIITE trial of RGX─121 for...

Sorry! Image not available at this time

Worldwide Clinical Trials - APAC: Clinician Rater - Australia - (Contractor)

pharmiweb.com - 03/Sep 00:00

Competitive: Worldwide Clinical Trials - APAC: Who we are We’re a global, midsize CRO that pushes boundaries, innovates and invents because the...